Glaxo Group Ltd. et al v. Aurobindo Pharma USA, Inc. et al > Summary
Court Case Number 1:17-cv-01862
Filing Date Dec 27, 2017
Termination Date Feb 6, 2018
Court Delaware District Court
Status Dismissed - Voluntarily
JudgesVacant Judgeship, Sherry R. Fallon
Plaintiff Attorneys
10Glaxo Group Limited
Attorney Name: Brian E. Farnan
Farnan LLP
Glaxo Group Limited
Attorney Name: Michael J. Farnan
Farnan LLP
GlaxoSmithKline
Attorney Name: Brian E. Farnan
Farnan LLP
GlaxoSmithKline
Attorney Name: Michael J. Farnan
Farnan LLP
Glaxo Group Limited
Attorney Name: Lisa M. Ferri
Mayer Brown
Glaxo Group Limited
Attorney Name: Colleen Tracy James
Mayer Brown
Glaxo Group Limited
Attorney Name: Scott A. McMurry
Mayer Brown
GlaxoSmithKline
Attorney Name: Lisa M. Ferri
Mayer Brown
GlaxoSmithKline
Attorney Name: Colleen Tracy James
Mayer Brown
GlaxoSmithKline
Attorney Name: Scott A. McMurry
Mayer Brown
Defendant Attorneys
Aurobindo Pharma USA
Attorney Name: Steven Jerome Moore
Withersworldwide
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09144547 | Oral dosage form for controlled drug release | Sep 29, 2015 |
| 08637512 | Formulations and method of treatment | Jan 28, 2014 |
